Table 5.
Patient | Medication(s) Added | Reason for Medication | Days After Sildenafil Initiation | Days of Medication Use | Remained on drug at latest follow-up |
---|---|---|---|---|---|
1 | Bosentan | Sildenafil intolerance | 950 | 155 | Yes |
2 | CCB | Lack of echocardiogram improvement | 75 | 269 | Yes |
3 | Epoprostenol | Lack of echocardiogram improvement | 18 | 10 | No |
4 | CCB | Systemic hypertension | 66 | 66 | Yes |
5 | Bosentan | Lack of echocardiogram improvement | 108 | 490 | No |
6 | Bosentan | Lack of echocardiogram improvement | 129 | 112 | Yes |
7 | Epoprostenol | Lack of echocardiogram improvement | 16 | 28 | No |
Bosentan | Lack of echocardiogram improvement | 56 | 191 | Yes |
PH = pulmonary hypertension; CCB = calcium channel blocker